Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeed Regulatory News (SEED)

Share Price Information for Seed (SEED)

Share Price is delayed by 15 minutes
Get Live Data
2.95    -0.05 (-1.67%)
Bid:
2.70
Ask:
3.20
Spread: 0.50 (18.519%)
Market Cap: £5.55m
SEED Live PriceLast checked at - London Stock Exchange

Intraday Seed Share Chart

Holding(s) in Company

2 Nov 2023 11:42

RNS Number : 2197S
Seed Innovations Limited
02 November 2023
Β 

Β 

Please note that from 22 March 2021, the Standard TR-1 Form should be completed and submitted to the FCA via our Electronic Submission System (ESS) in relation to notifications of voting rights held in issuers whose shares are admitted to trading on UK regulated markets.

Β 

Holders of voting rights in issuers whose shares are admitted to trading on UK prescribed markets such as AIM market, can continue to use this form to send their notifications to those issuers. Alternatively, if they wish they can register on ESS to be able to notify to us, produce a TR-1 Form via ESS and submit the downloaded version to issuers with shares admitted to trading on prescribed markets.

Β 

More information on how to submit a TR-1 Form via ESS is available here

Β 

Β 

TR-1: Standard form for notification of major holdings

Β 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:

Seed Innovations Limited

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify) iii:

3. Details of person subject to the notification obligation iv

Name

Jim Mellon

City and country of registered office (if applicable)

Isle of Man

4. Full name of shareholder(s) (if different from 3.) v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reached vi:

31 October 2023

6. Date on which issuer notified (DD/MM/YYYY):

1 November 2023

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer (8.A + 8.B) vii

Resulting situation on the date on which threshold was crossed or reached

9.26%

19,921,908

Position of previous notification (if

applicable)

7.57%

16,283,722

Β 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached viii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rights ix

% of voting rights

Direct

(DTR5.1)

Indirect

Β (DTR5.2.1)

Direct

(DTR5.1)

Indirect

(DTR5.2.1)

Seed Innovations Ltd

19,921,908

9.26%

SUBTOTAL 8. A

19,921,908

9.26%

Β 

Β 

B 1: Financial Instruments according to DTR5.3.1R (1) (a)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

Β 

Β 

B 2: Financial Instruments with similar economic effect according to DTR5.3.1R (1) (b)

Type of financial instrument

Expirationdate x

Exercise/Conversion Period xi

Physical or cash

Settlement xii

Number of voting rights

% of voting rights

Β 

SUBTOTAL 8.B.2

Β 

Β 

Β 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer xiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entity (please add additional rows as necessary) xiv

Name xv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Β 

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional information xvi

Β 

Place of completion

Douglas, Isle of Man

Date of completion

1 November 2023

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
HOLUUSARORUARAA
Date   Source Headline
7th May 20267:00 amRNSInvestment in Feather Robotics, Inc.
1st May 20267:00 amRNS-RInvestee Company Update: Little Green Pharma
15th Apr 20267:00 amRNS-RInvestor Presentation
14th Apr 20267:00 amRNSInvestment in Clean Food Group Funding Round
23rd Feb 20262:47 pmRNS-RInvestor Presentation Update
11th Feb 20267:00 amRNS-RInvestor Presentation
14th Jan 20262:46 pmRNSInvestee Company Update: Little Green Pharma
9th Jan 20263:19 pmRNSDirector's Dealing
23rd Dec 20257:00 amRNSAppointment of Specialist Investment Consultant
23rd Dec 20257:00 amRNSAppointment of Specialist Investment Consultant
10th Dec 202510:49 amRNS-RInvestor Presentation Postponed
8th Dec 20252:30 pmRNS-RIntroduction to Newly Appointed Directors
4th Dec 20257:00 amRNSInterim Results
26th Nov 20257:00 amRNSBoard Appointments
13th Nov 202510:07 amRNS-RInvestee Company Update: Little Green Pharma Ltd
25th Sep 20257:00 amRNS-RInvestee Company Update: Clean Food Group
18th Sep 20257:00 amRNSHolding(s) in Company
11th Sep 20257:00 amRNSHolding(s) in Company
10th Sep 20259:11 amRNSHolding(s) in Company
8th Sep 202511:01 amRNSResult of Tender Offer
14th Aug 20257:00 amRNSDirectorship Changes
14th Aug 20257:00 amRNSTender Offer
13th Aug 20253:09 pmRNSResult of AGM
5th Aug 20251:39 pmRNSHolding(s) in Company
1st Aug 202510:55 amRNSHolding(s) in Company
18th Jul 20257:00 amRNSNotice of AGM & Publication of Circular
18th Jul 20257:00 amRNSInvestee Company Update: Little Green Pharma Ltd
17th Jul 20257:00 amRNSDivestment of Oxford BioDynamics Position
20th Jun 20257:00 amRNSFinal Results
30th May 20252:33 pmRNS-RInvestee Company Update: Little Green Pharma Ltd
28th May 20258:03 amRNSHolding(s) in Company
23rd May 20257:41 amRNSHolding(s) in Company
22nd May 20257:00 amRNSInvestee Company Update: Juvenescence Ltd
30th Apr 202512:13 pmRNSInvestee Company Update: Little Green Pharma Ltd
30th Apr 202510:48 amRNSHolding(s) in Company
17th Apr 20257:00 amRNSHolding(s) in Company
7th Apr 20251:35 pmRNSHolding(s) in Company
28th Mar 20257:00 amRNS-RNew Corporate Presentation
25th Feb 20253:08 pmRNSHolding(s) in Company
5th Feb 202510:44 amRNSInvestee Company Update: Little Green Pharma Ltd
31st Jan 20251:02 pmRNSHolding(s) in Company
31st Jan 202512:38 pmRNSInvestee Company Update: Little Green Pharma Ltd
16th Jan 20257:00 amRNS-R2025 New Year Statement
20th Dec 20242:19 pmRNS-RInvestee Company Update: Little Green Pharma Ltd
10th Dec 20247:07 amRNSHolding(s) in Company
3rd Dec 20247:00 amRNSHalf-year Report
11th Nov 202412:43 pmRNSPortfolio Update
17th Oct 202412:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
8th Oct 20247:24 amRNSPortfolio Update
24th Sep 20247:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.